Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
House approves bill to limit pharmaceutical firms— ability to restrict 340B contract pharmacies
Summary
Lawmakers passed Senate Bill 154 to bar drug manufacturers from restricting 340B drug sales to contract pharmacies, with supporters saying the change protects rural hospitals and community pharmacies.
The South Dakota House passed Senate Bill 154 on March 5, 2025, a bill aimed at preventing pharmaceutical manufacturers from restricting 340B pricing to contract pharmacies and protecting rural hospital and pharmacy revenue streams.
Representative Rayfeld, the bill's floor sponsor, told the chamber the 340B Drug Pricing Program is a federal program designed to help safety‑net providers extend scarce resources and that recent manufacturer restrictions have "severely impacted…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
